Antibody treatment reduces asthma attacks in children living in disadvantaged urban areas

A monoclonal antibody drug called mepolizumab decreased asthma attacks by 27% in children and adolescents who have a form of severe asthma, are prone to asthma attacks and live in low-income urban neighborhoods, according to a clinical trial spons… Read More 

Generated by Feedzy